Read More 1 minute read Earnings LivePerson’s Earnings: A Preview By Benzinga Insights Today, 8:41 AM LivePerson (NASDAQ:LPSN) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here’s what investors need… LPSN
Read More 1 minute read Earnings Earnings Preview: Owlet By Benzinga Insights Today, 8:41 AM Owlet (NYSE:OWLT) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here’s what investors need… OWLT
Read More 2 minute read Markets Options NVIDIA Unusual Options Activity By Benzinga Insights Today, 8:41 AM Someone with a lot of money to spend has taken a bearish stance on NVIDIA (NASDAQ:NVDA). And retail… NVDA
Read More 2 minute read Movers Trading Ideas Insurance Stocks Moving In Tuesday’s Intraday Session By Benzinga Insights Today, 8:41 AM According to Benzinga Pro following are the gainers and losers in Insurance industry for today’s Intraday session. Gainers… BHFAM
Read More 2 minute read Movers 12 Financials Stocks Moving In Tuesday’s Intraday Session By Benzinga Insights Today, 8:41 AM Gainers PacWest Bancorp – Depositary Shares Each Representing a 1/40th Interest in a Share of 7.75% Fixed Rate… FFWM
Read More 6 minute read Options Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights Today, 8:41 AM Tuesday's morning session saw 84 companies set new 52-week lows. AAP
Read More 1 minute read Earnings MorphoSys’s Earnings Outlook By Benzinga Insights Today, 8:41 AM MorphoSys (NASDAQ:MOR) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here’s what investors need… MOR
Read More 2 minute read Analyst Ratings Analyst Ratings for Wintrust Finl By Benzinga Insights Today, 8:41 AM Over the past 3 months, 4 analysts have published their opinion on Wintrust Finl (NASDAQ:WTFC) stock. These analysts… WTFC
Read More 2 minute read Analyst Ratings Analyst Expectations for Amylyx Pharma’s Future By Benzinga Insights Today, 8:41 AM Over the past 3 months, 5 analysts have published their opinion on Amylyx Pharma (NASDAQ:AMLX) stock. These analysts… AMLX
Read More 2 minute read Analyst Ratings Citigroup Maintains Neutral Rating for Visteon: Here’s What You Need To Know By Benzinga Insights Today, 8:41 AM Citigroup has decided to maintain its Neutral rating of Visteon (NASDAQ:VC) and raise its price target from $145.00… VC